Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trachyspermum ammi vs mefenamic acid for primary dysmenorrhea
IRCT20180805040697N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Mefenamic acid in primary dysmenorrhea (PD) (2 arms), sponsored by Iran University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
Mefenamic acid
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20180805040697N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180805040697N1.